Login / Signup

Comparison of treatment strategies for resectable locally advanced primary mucinous adenocarcinoma of the lung.

Yu GuHongcheng ZhuJiaying DengJunhua ZhangTianxiang ChenSongtao Lai
Published in: Cancer medicine (2023)
The prognosis of patients with resectable III-N2 primary lung PMA was significantly worse than that of other ADCs, and PORT was an independent prognostic factor. Patients with ≤7 positive lymph nodes could benefit from PORT and those with >7 positive lymph nodes could benefit from chemotherapy.
Keyphrases
  • locally advanced
  • lymph node
  • rectal cancer
  • prognostic factors
  • neoadjuvant chemotherapy
  • squamous cell carcinoma
  • radiation therapy
  • phase ii study
  • sentinel lymph node
  • robot assisted
  • low grade
  • clinical trial